Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Molecular biologist warns of vCJD (variant Creutzfeldt Jakob disease) incidence:

This article was originally published in Clinica

Executive Summary

A senior German molecular biologist has warned that Germany could be faced with up to 12 cases of new variant Creuzfeldt Jakob Disease (vCJD) within the next two years. Professor Konrad Beyreuther from the University of Heidelberg bases his estimate on data gathered from vCJD incidence in the UK, but further advises that the disease could manifest itself in Germany in the form of another variant. An extrapolation of UK data shows that Germany could have up to 1,200 BSE-infected cattle.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel